Literature DB >> 35957946

Influence of Breast Reduction Surgery on Long-Term Breast Cancer Risk in Austria.

Albert Niepel1, Sven Schwake1, Mira Zeichmann2, Ariel Noltze1, Viktoria König2, Fuat Sokullu1, Clara Schenk2, Shanon Pallikunnel1, Dirk Hellekes1, Rupert Koller1,3, Lara Steinkellner1.   

Abstract

Introduction: Breast reduction surgery is one of the most frequently performed surgeries amongst plastic and reconstructive surgeons worldwide. Previous studies have shown decreased risk of breast cancer development in women undergoing breast reduction surgery of up to 28%. We aimed to evaluate the relative risk of breast cancer development in our patients after breast reduction surgery in relation to the general female population of Austria.
Methods: A total of 637 women underwent breast reduction surgery between 2003 and 2017 at our department. From those women, 513 patients completed a follow-up assessment of breast cancer development and were included into the study sample. The age-specific incidence rate data of the general female population of Austria served as the control group and basis for the calculation of the standardized incidence ratio (SIR) and Poisson test.
Results: Relative to 5.66 expected cases of breast cancer, our cohort showed 1 subject with breast cancer after breast reduction surgery (SIR = 0.1765). An exact Poisson test was carried out to determine the level of significance of the difference between the incidence rate observed in the sample compared to the expected rate based on the age-specific incidence rates of the general population (p = 0.023, α = 0.05). Discussion: Our study underlines the strong evidence of previous studies for significant breast cancer reduction in patients after reductive mammoplasty. In comparison to the general female population of Austria, our cohort showed a reduction in breast cancer incidence of about 82%. The authors believe that different techniques in reduction mammoplasty have different levels of safety regarding the prevention and risk reduction for breast cancer. Further investigation must be conducted to evaluate the reduction of breast cancer risk with different surgical techniques.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  Breast cancer; Female carcinoma; Long-term follow-up; Mamma tumor; Prevalence; Prevention; Reductive mammoplasty

Year:  2021        PMID: 35957946      PMCID: PMC9247527          DOI: 10.1159/000517816

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.268


  9 in total

1.  Prophylactic mastectomy in women with a high risk of breast cancer.

Authors:  V L Ernster
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

2.  Clinical outcomes in reduction mammaplasty: a systematic review and meta-analysis of published studies.

Authors:  E B Chadbourne; S Zhang; M J Gordon; E Y Ro; S D Ross; P L Schnur; P R Schneider-Redden
Journal:  Mayo Clin Proc       Date:  2001-05       Impact factor: 7.616

3.  A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women.

Authors:  Jon P Fryzek; Weimin Ye; Olof Nyrén; Robert E Tarone; Loren Lipworth; Joseph K McLaughlin
Journal:  Breast Cancer Res Treat       Date:  2005-12-03       Impact factor: 4.872

4.  Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years.

Authors: 
Journal:  Breast Cancer Res Treat       Date:  2007-10-31       Impact factor: 4.872

5.  Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden.

Authors:  L A Brinton; I Persson; J D Boice; J K McLaughlin; J F Fraumeni
Journal:  Cancer       Date:  2001-02-01       Impact factor: 6.860

6.  Breast cancer following breast reduction surgery in Sweden.

Authors:  J D Boice; I Persson; L A Brinton; M Hober; J K McLaughlin; W J Blot; J F Fraumeni; O Nyrén
Journal:  Plast Reconstr Surg       Date:  2000-09       Impact factor: 4.730

7.  Smoking and physical inactivity increase cancer prevalence in BRCA-1 and BRCA-2 mutation carriers: results from a retrospective observational analysis.

Authors:  Sabine Grill; Maryam Yahiaoui-Doktor; Ricarda Dukatz; Jacqueline Lammert; Mirjam Ullrich; Christoph Engel; Katharina Pfeifer; Maryam Basrai; Michael Siniatchkin; Thorsten Schmidt; Burkhard Weisser; Kerstin Rhiem; Nina Ditsch; Rita Schmutzler; Stephan C Bischoff; Martin Halle; Marion Kiechle
Journal:  Arch Gynecol Obstet       Date:  2017-10-03       Impact factor: 2.344

8.  Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study.

Authors:  Cina J Nattenmüller; Mark Kriegsmann; Disorn Sookthai; Renée Turzanski Fortner; Annika Steffen; Britta Walter; Theron Johnson; Jutta Kneisel; Verena Katzke; Manuela Bergmann; Hans Peter Sinn; Peter Schirmacher; Esther Herpel; Heiner Boeing; Rudolf Kaaks; Tilman Kühn
Journal:  BMC Cancer       Date:  2018-05-31       Impact factor: 4.430

9.  Tumour location within the breast: Does tumour site have prognostic ability?

Authors:  Seth Rummel; Matthew T Hueman; Nick Costantino; Craig D Shriver; Rachel E Ellsworth
Journal:  Ecancermedicalscience       Date:  2015-07-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.